To the Editor: We read with great interest the report by François Lespérance, M.D., and colleagues (1) about the relationship of inflammatory markers to major depression in patients with cardiac disease. They noted one previously published study that found an association between interleukin-1β and interleukin-6 levels and depression in patients about to undergo angioplasty (2). We wish to consider their results in the context of a previously published pilot study by our group (3), in which we found that serum interleukin-1β level was not associated with depressive symptoms or diagnosis in 37 patients age 50 years and older with coronary artery disease who were recruited from a cardiac rehabilitation program. Our negative results are consistent with those of Dr. Lespérance et al., who did not find an association between depression and interleukin-6 or C-reactive protein levels. They thoughtfully considered the possibility that statins might obscure any relationship between such inflammatory markers and depression. We add that a similar confound may be posed by the overall burden of medical illness, which was correlated with interleukin-1β level in our study group. The obscuration of any depression-inflammatory marker relationship may be particularly important in older patients, with their greater physical comorbidities. Also, times of acute cardiac exacerbation, with concomitant increases in levels of inflammatory markers, may make the association with depression most evident. This may help explain the positive findings of Appels et al. (2).